Abstract

Purpose:To investigate the feasibility of using an inverse planning technique for CT-based ring and tandem high-dose rate brachytherapy of cervical cancer. Methods and Materials:Two patients previously treated with high-dose-rate brachytherapy for cervical cancer were retrospectively identified for this study. Each patient had five intracavitary insertions using CT/MR-compatible tandem and ring applicators. The 6Gy isodose lines from the original clinical plans were converted into a structure set (S6) using MIMvista. Inverse plans were then generated in Oncentra using the inverse planning simulated annealing (IPSA) with S6 as the optimization target. The dose to 0.1cm3, 1cm3, 5cm3 of bladder (DB0.1, DB1, and DB5) and rectum (DR0.1, DR1, DR5) were determined from the dose volume histogram (DVH). Percentage of physician drawn clinical target volume (CTV) and S6 coverage (V100CTV, V100S6) were also recorded. Results:The mean V100%CTV of the original clinical plans and the inverse plans were 88.14% and 87.57%. The mean V100%S6 of the original clinical plans and the inverse plans was 98.68% and 97.00%. The mean dose reduction for DB0.1, DB1 and DB5 were 5.4%, 5.4%, and 4.7%, respectively. The mean dose reduction for DR0.1, DR1 and DR5 were 6.4%, 5.5%, and 4.8%. Conclusions:This work demonstrated the feasibility of this structure-based inverse planning. It can achieve comparable CTV coverage while reducing dose to critical structures. Once template structure set is constructed, this procedure can not only reduce planning time, but improve quality assurance by standardizing the procedure. This approach can be directly extended to other applicator-based brachytherapy procedures.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.